The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes

Study of MAXimum Weight in Lifetime on Glucose Homeostasis (MAXWEL)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00816608

Acronym

MAXWEL

Enrollment

3000

Registered

2009-01-01

Start date

2006-08-31

Completion date

2013-09-30

Last updated

2013-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Prediabetes

Keywords

diabetes, prediabetes, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), body weight

Brief summary

Hypothesis : The maximum body weight in lifetime is associated with the onset of development of type 2 diabetes.

Detailed description

Obesity is well recognized risk factor for type 2 diabetes. Recent studies reported that weight change, especially severe weight gain was associated with an increased risk of type 2 diabetes. The aim of this study is to investigate whether the maximum body weight of lifetime is associated with the early onset of type 2 diabetes or an increased risk of type 2 diabetes in Korean.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Korean with type 2 diabetes * Korean with confirmed IFG or IGT * Korean with NGT

Exclusion criteria

* Malignancy except thyroid cancer * Active tuberculosis

Design outcomes

Primary

Measure	Time frame
The development of diabetes	Five years

Secondary

Measure	Time frame
DM complication	5 years

Countries

South Korea

Outcome results